STAAR Surgical (STAA) Tops Q1 EPS by 5c, Beats on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to STAAR Surgical (STAA) Tops Q1 EPS by 5c, Beats on Revenue

STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter

May 13, 2026 4:01 PM EDT

Net Sales of $93.5 million, highest first quarter Net Sales in Companys history, up 119.6% Y/Y

Net Income of $5.2 million, with GAAP EPS of $0.10

Adjusted EBITDA1 of $24.4 million, or $0.48 per diluted share

Earnings Call and Webcast Today at 5:30 PM Eastern

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today reported results for the first quarter... More